A significant correlation between C - Reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Kaplan, Marielle ^a   Hamoud, Shadi ^b   Tendler, Yevgeny ^a   Meilin, Edna ^c   Lazarovitch, Aviva ^c   Nitecki, Samy ^b   Hayek, Tony ^b,c  

^a Clinical Biochemistry and Laboratory Medicine   (Israel)

^b Department of Internal Medicine e Rambam Health Care Campus ^*  (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Macrophages

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MESSENGER RNA;

AGED; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRP GENE; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID ANALYSIS; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; TISSUE LEVEL;

EID: 84896128597     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-7     Document Type: Article

References (35)

1. Inflammation in atherosclerosis. Libby P, Arterioscler Thromb Vasc Biol 2012 32 2045 2051 10.1161/ATVBAHA.108.179705 22895665
2. Inflammation and atherosclerosis. Barton M, Minotti R, Haas E, Circ Res 2007 101 750 751 10.1161/CIRCRESAHA.107.162487 17932331 (Pubitemid 350287187)
3. Atherosclerosis. Lusis AJ, Nature 2000 407 233 241 10.1038/35025203 11001066
4. Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: Role of insulin therapy. Kaplan M, Aviram M, Hayek T, Pharmacol Ther 2012 136 175 185 10.1016/j.pharmthera.2012.08.002 22890211
5. C-reactive protein: a critical update. Pepys MB, Hirschfield GM, J Clin Invest 2003 111 1805 1812 10.1172/JCI200318921 12813013 (Pubitemid 38057722)
6. A proatherogenic role for C-reactive protein in vivo. Paul A, Yeh ET, Chan L, Curr Opin Lipidol 2005 16 512 517 10.1097/01.mol.0000180164.70077.a7 16148535 (Pubitemid 41376900)
7. The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Abd TT, Eapen DJ, Bajpai A, Goyal A, Dollar A, Sperling L, Curr Atheroscler Rep 2011 13 154 161 10.1007/s11883-011-0164-5 21274757
8. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Ridker PM, Am Heart J 2004 148 19 S26 10.1016/j.ahj.2004.04.028 15211329 (Pubitemid 38887094)
9. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J, C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), BMJ 2011 342 548 21325005
10. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Verma S, Devaraj S, Jialal I, Circulation 2006 113 2135 2150 16671184
11. C-reactive protein and coronary disease: is there a causal link? Danesh J, Pepys MB, Circulation 2009 120 2036 2039 10.1161/CIRCULATIONAHA.109.907212 19901186
12. Proinflammatory cytokines in CRP baseline regulation. Eklund CM, Adv Clin Chem 2009 48 111 136 19803417
13. Cardiovascular biology of interleukin-6. Abeywardena MY, Leifert WR, Warnes KE, Varghese JN, Head RJ, Curr Pharm Des 2009 15 1809 1821 10.2174/138161209788186290 19442192
14. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Zhang YX, Cliff WJ, Schoefl GI, Higgins G, Atherosclerosis 1999 145 375 379 10.1016/S0021-9150(99)00105-7 10488966 (Pubitemid 29359147)
15. Generation of C-reactive protein and complement components in atherosclerotic plaques. Yasojima K, Schwab C, McGeer EG, McGeer PL, Am J Pathol 2001 158 1039 1051 10.1016/S0002-9440(10)64051-5 11238052 (Pubitemid 32221796)
16. High glucose regulates C-reactive protein production in macrophages. Kaplan M, Tendler Y, Mahamid R, Shiner M, Aviram M, Hayek T, Clin Chem 2010 56 1036 1038 10.1373/clinchem.2009.136838 20348407
17. Production of modified CRP in U937-derived macrophages. Ciubotaru I, Potempa LA, Wander RC, Exp Biol Med 2005 230 762 770 (Pubitemid 41565946)
18. Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue. Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, Jahrbeck B, Sievers HH, Steinhoff J, Bartels C, Circulation 2003 108 1428 1431 10.1161/01.CIR.0000092184.43176.91 12975260 (Pubitemid 37176446)
19. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary Arteries. Torzewski J, Torzewski M, Bowyer DE, Fröhlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V, Arterioscler Thromb Vasc Biol 1998 18 1386 1392 10.1161/01.ATV.18.9.1386 9743226 (Pubitemid 28421875)
20. Mineralocorticoid receptor blocker increases Angiotensin-converting enzyme 2 activity in congestive heart failure patients. Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R, Abassi Z, Circ Res 2005 97 946 953 10.1161/01.RES.0000187500.24964.7A 16179584 (Pubitemid 41552681)
21. A comparison of two immunoperoxidase staining methods based on the avidin -biotin interaction. Giorno R, Diagn Immunol 1984 2 161 166 6388981 (Pubitemid 15189772)
22. Green FJ, The Sigma-Aldrich Handbook of Stains, Dyes & Indicators Milwaukee, WI: Published by Aldrich Chemical Co, Green FJ, 1990 565 567
23. Advanced end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Basta G, Schmidt AM, De Caterina R, Cardiovasc Res 2004 63 582 592 10.1016/j.cardiores.2004.05.001 15306213 (Pubitemid 39078671)
24. Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque. Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F, Olgun A, Sanisoglu SY, Baysan O, Yildiz O, Taslipinar A, Tatar H, Kutlu M, Ozata M, Clin Exp Immunol 2006 143 452 457 10.1111/j.1365-2249.2006.03025.x 16487244
25. C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. Turk JR, Carroll JA, Laughlin MH, Thomas TR, Casati J, Bowles DK, Sturek M, J Appl Physiol 2003 95 1301 1304 12754176 (Pubitemid 37034029)
26. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Venugopal SK, Devaraj S, Jialal I, Curr Opin Nephrol Hypert 2005 14 33 37 10.1097/00041552-200501000-00006 (Pubitemid 40110697)
27. Sources of CRP in atherosclerotic lesions. Jialal I, Devaraj S, Singh U, Am J Pathol 2006 168 1054 1055 10.2353/ajpath.2006.051175 16507918 (Pubitemid 43327755)
28. CRP as mediator of disease. Yeh ET, Circulation 2004 109 II 11 14
29. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Waldo SW, Li Y, Buono C, Zhao B, Billings EM, Chang J, Kruth HS, Am J Pathol 2008 172 1112 1126 10.2353/ajpath.2008.070513 18321997 (Pubitemid 351520007)
30. Monocyte and macrophage dynamics during atherogenesis. Ley K, Miller YI, Hedrick CC, Arterioscler Thromb Vasc Biol 2011 31 1506 1516 10.1161/ATVBAHA.110. 221127 21677293
31. CRP or not CRP? That is the question. Pepys MB, Arterioscler Thromb Vasc Biol 2005 25 1091 1094 10.1161/01.ATV.0000169644.88847.28 15923540 (Pubitemid 40776591)
32. C-reactive protein, fibrinogen, and cardiovascular disease prediction. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Emerging Risk Factors Collaboration, et al. N Engl J Med 2012 367 1310 1320 23034020
33. Identification of acidic pH-dependent ligands of pentameric C-reactive protein. Hammond DJ Jr, Singh SK, Thompson JA, Beeler BW, Rusiñol AE, Pangburn MK, Potempa LA, Agrawal A, J Biol Chem 2010 285 36235 36244 10.1074/jbc.M110.142026 20843812
34. Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis. Singh SK, Thirumalai A, Hammond DJ Jr, Pangburn MK, Mishra VK, Johnson DA, Rusiñol AE, Agrawal A, J Biol Chem 2012 287 3550 3558 10.1074/jbc.M111.310011 22158621
35. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, Haviv I, Peter K, Basic Res Cardiol 2011 106 879 895 10.1007/s00395-011-0191-y 21562922